NVRO News and Press, Nevro Corp. From 05/09/23

2023-05-09 22:13:10 ET Summary Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts could bring significant FCF growth and stock price ap...

Nevro Corp. Announces New Employment Inducement Grant under Section 303A.08 of the NYSE Listed Company Manual PR Newswire REDWOOD CITY, Calif. , April 27, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehens...

2023-04-26 21:34:24 ET The following slide deck was published by Nevro Corp. in conjunction with their 2023 Q1 earnings call. For further details see: Nevro Corp. 2023 Q1 - Results - Earnings Call Presentation

2023-04-26 21:34:07 ET Nevro Corp. (NVRO) Q1 2023 Earnings Conference Call April 26, 2023, 4:30 PM ET Company Participants Julie Dewey - Chief Corporate Communications and Investor Relations Officer Keith Grossman - Executive Chairman Kevin Thornal - President an...

2023-04-26 16:48:46 ET Nevro press release ( NYSE: NVRO ): Q1 GAAP EPS of -$0.98 beats by $0.06 . Revenue of $96.3M (+9.6% Y/Y) beats by $0.95M . First Quarter 2023 Non-GAAP Adjusted EBITDA Loss of $17.1M. Guidance: Provides Second Quarter 2023 Revenue ...

Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance PR Newswire REDWOOD CITY, Calif. , April 26, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is de...

2023-04-25 17:35:58 ET Nevro ( NYSE: NVRO ) is scheduled to announce Q1 earnings results on Wednesday, April 26th, after market close. The consensus EPS Estimate is -$1.09 and the consensus Revenue Estimate is $95.35M (+8.5% Y/Y). Over the last 1 year, NVRO has beate...

Nevro Announces Enrollment of First Patient in PDN Sensory Study PR Newswire First Randomized Controlled Trial Specifically Powered to Assess Restoration of Neurological Function in Patients with Intractable Painful Diabetic Neuropathy Breakthrough Device Designa...

Nevro Announces Participation in Upcoming Investor Conferences PR Newswire REDWOOD CITY, Calif. , April 24, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treat...

2023-04-20 12:54:06 ET Gainers: Augmedix ( AUGX ) +68% . CNS Pharmaceuticals ( CNSP ) +65% . United Insurance Holdings ( UIHC ) +49% . Tenaya Therapeutics ( TNYA ) +27% . Brenmiller Energy ( BNRG ) +23% . VCI Global Limited (...